P2.12. Treatment Patterns and Clinical Outcomes in Patients with EGFR-mutant NSCLC after Progression on First-Line Osimertinib - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Sarah Goldberg
Meta Tag
Speaker Sarah Goldberg
Topic Metastatic NSCLC: Targeted Therapy - Other
EGFR-mutant non-small cell lung cancer
treatment patterns
clinical outcomes
retrospective analysis
second-line treatment
EGFR mutations
progression-free survival
individualized treatment strategies
Powered By